Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Seminars in Hematology|May 29, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk diseasePrashant Kapoor, Meletios A Dimopoulos, Stephen M Ansell, et al.
Acta Dermato-Venereologica|June 4, 2020
Cutaneous Involvement in Waldenström's MacroglobulinaemiaSarah Stien, Eric Durot, Anne Durlach, et al.
Seminars in Hematology|May 17, 2025
Report of Consensus Panel 6 from the 12th International Workshop on Waldenström's Macroglobulinemia on Diagnosis and Management of Transformed Waldenström's MacroglobulinemiaEric Durot, Jithma P Abeykoon, Damien Roos-Weil, et al.
Leukemia|May 24, 2019
A revised international prognostic score system for Waldenström's macroglobulinemiaEfstathios Kastritis, Pierre Morel, Alain Duhamel, et al.
Blood|April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemiaEric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
British Journal of Haematology|August 4, 2017
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)Eric Durot, Cécile Tomowiak, Anne-Sophie Michallet, et al.
Bone Marrow Transplantation|January 19, 2020
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centersThomas Hueso, Thomas Gastinne, Sylvain Garciaz, et al.
Blood Advances|December 8, 2022
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA groupRaphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, et al.
Haematologica|May 28, 2026
Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa studyJulien Lazarovici, Sandy Amorim, Krimo Bouabdallah, et al.
Hematological Oncology|July 12, 2025
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell LymphomaJuliette Penichoux, Pierre Decazes, Cédric Rossi, et al.
Pageof 6